News About: Pharm. Industry
Yuhan Corporation ‘certain’ to generate 2 medicines of KRW 100 billion salesYuhan Corporation, the top sales company in the pharmaceutical industry, is certain to generate 2 super blockbuster medicines with more than KRW 100 billion annual sales.
Accor...
|
Large-scale international event proposing Korean pharma industry’s growth roadmap
Jointly hosted by UBM, a global events organizer, and the Korea Pharmaceutical Traders Association(KPTA) and sponsored by the Ministry of Food and Drug Safety, Chungbuk Technopark, the Korea Federation of SMEs, the Ko...
More pharma sales reps having multiple jobs
It seems there are more sales representatives having multiple jobs at pharmaceutical companies.
While having sales activities for products of the company they belong, these representatives are making extra earnings b...
Ildong’s ‘Besivo’ shows equivalence and improved safety to Viread
“Besivo, a chronic hepatitis B treatment, is a product which proved equivalent efficacy and improved safety to Viread.”
Ildong Pharmaceutical held a press conference for ‘Besivo Tab,’ a new chronic hepatitis B treatm...
Rapid decrease in products bioequivalently approved
There were 227 pharmaceutical products newly approved in bioequivalence test this year, decreased by more than 40% compared to the same period of the last year.
On the 22nd of May, the Ministry of Food and Drug Safet...
4 types of pet vaccines and Heartgard excluded from range of veterinary prescription drugs
The ‘Range of Pharmaceutical Products Prescribed as Veterinary Drug,’ which may have caused high medical expenses for animal treatment by restricting treatment options in the circumstance where pet insurance is not ap...
Gems Korea supplies entire products of Mölnlycke Health Care across the nation
Gems Korea(CEO Young-Suh Park) has started to supply the entire products of Mölnlycke Health Care(CEO Seung-Woon Kim), a leading pharmaceutical company in the scar treatment field, to hospitals across the nation since...
Samil Pharmaceutical signs MOU to develop innovative products with Yozma Group KoreaSamil Pharmaceutical(CEO Seung-Bum Huh) signed a memorandum of understanding for strategic partnership and commercialization of innovative new products related to medicine, heal...
|
SamjinPharm’s ‘Research for Targeted Therapy for Metastatic Breast Cancer’ selected for government’s supportSamjinPharm(CEO Sung-Woo Lee) Central Laboratory announced its ‘Development Project of Targeted Therapy for Metastatic Breast Cancer Patients’ was selected as part of the ‘New D...
|
Il-Yang Pharmaceutical, “Wonbi-D exceeded KRW 30 billion sales in China last year”Il-Yang Pharmaceutical’s ‘Wonbi-D’ continues its rapid growth as recording more than KRW 30 sales in China.
According to the company, the ‘Wonbi-D’ sales have been increased ev...
|
